Contattaci Contact Us

VGFM DATA-LAYER

Dettagli dell'Evento:

EARLY-ONSET COLORECTAL CANCER Delphi initiative recommendations on EO-CRC (DIRECt): the path to improve diagnosis and clinical management

01 settembre 2022 - Giorno 1

  • Live Streaming 1 settembre 2022

    Relatore -

    Data Intervento 01/09/2022 - 08:20

  • Welcome greetings

    Relatore Giulia Martina Cavestro

    Data Intervento 01/09/2022 - 08:30

  • What is the global epidemiology and age cut-off to define eoCRC? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Caitlin C. Murphy

    Data Intervento 01/09/2022 - 09:00

  • Which symptoms and clinical signs prompt evaluation for eoCRC? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Sonia Kupfer

    Data Intervento 01/09/2022 - 09:20

  • Which test(s) and what should be the time frame for evaluation of symptoms and signs of eoCRC? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Swati G. Patel

    Data Intervento 01/09/2022 - 09:40

  • PROS: E. Stoffel

    Relatore Elena Stoffel

    Data Intervento 01/09/2022 - 10:50

  • CONS: E. Dekker

    Relatore Evelien Dekker

    Data Intervento 01/09/2022 - 11:05

  • How can family history influence in eoCRC detection? What other risk factors in assessing an individual’s risk for eoCRC? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore M. De Los Angeles Daca-Alvarez

    Data Intervento 01/09/2022 - 11:20

  • INTRODUCTION - LECTURE

    Relatore Luigi A. G. Laghi

    Data Intervento 01/09/2022 - 12:00

  • Who should receive germline genetic testing among eoCRC patients, and when should this take place? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Dominguez-Valentin Mev

    Data Intervento 01/09/2022 - 14:00

  • What genes should/could be included in germline multi-gene panel tests for eoCRC patients? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Heather Doll Hampel

    Data Intervento 01/09/2022 - 14:30

  • Could risk assessment tools be helpful for eoCRC patients? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Fay Kastrinos

    Data Intervento 01/09/2022 - 14:50

  • Demetra Project

    Relatore Marta Puzzono

    Data Intervento 01/09/2022 - 16:00

  • PLSD update

    Relatore Pål Møller

    Data Intervento 01/09/2022 - 16:15

  • Artificial intelligence relates to endoscopy for eoCRC diagnosis

    Relatore S. K. Singh

    Data Intervento 01/09/2022 - 16:30

  • The “REACCT Collaborative”

    Relatore Desmond Winter

    Data Intervento 01/09/2022 - 16:45

  • Artificial intelligence and OMICS integration on tumor response and clinical outcomes’ prediction in eoCRC patients

    Relatore Elisa Meldolesi

    Data Intervento 01/09/2022 - 17:15

  • Towards improved treatment strategies of early onset CRC

    Relatore Tineke Buffart

    Data Intervento 01/09/2022 - 17:30

  • Refining the age of CRC screening

    Relatore Alessandro Mannucci

    Data Intervento 01/09/2022 - 17:45

  • IANG-CRC study: an integrative omics approach to decipher mechanisms of cancer immunoediting as candidate targets of new therapies for eoCRC

    Relatore Gianluca Mauri

    Data Intervento 01/09/2022 - 18:00

02 settembre 2022 - Giorno 2

  • Live Streaming 2 settembre 2022

    Relatore -

    Data Intervento 02/09/2022 - 07:55

  • How to decide adjuvant postoperative treatment. Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Stefano Cascinu

    Data Intervento 02/09/2022 - 08:10

  • How to decide neoadjuvant treatment in eoCRC? Who to give it to and what to give? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Elisa Meldolesi

    Data Intervento 02/09/2022 - 08:20

  • Is immunohistochemistry/molecular microsatellite analysis for mismatch repair proteins necessary in eoCRC endoscopic biopsies?

    Relatore Andrea Remo

    Data Intervento 02/09/2022 - 09:00

  • Which criteria to select patients for fertility preservation and which information needs to be provided to preserve fertility and fecundity before and after treatment?

    Relatore Valeria Stella Vanni

    Data Intervento 02/09/2022 - 09:20

  • What diagnostic workup for eoCRC before surgical treatment? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Toni Seppala

    Data Intervento 02/09/2022 - 10:20

  • What modifications to surgical approach can be offered? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Gabriela Möslein

    Data Intervento 02/09/2022 - 10:40

  • What endoscopic technologies, standard quality metrics and follow-up schedule for eoCRC being treated either endoscopically or surgically? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Elena Stoffel

    Data Intervento 02/09/2022 - 11:20

  • Is there a place for endoscopic therapy of T1 cancers in patient with eoCRC? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Evelien Dekker

    Data Intervento 02/09/2022 - 11:40

  • Management of cancer-related symptoms in eoCRC, including pain, fatigue, nausea, vomiting, constipation, diarrhea and cachexia? Summary from the “DIRECT” recommendations and update from the last-year literature

    Relatore Andrea Sartore-Bianchi

    Data Intervento 02/09/2022 - 14:30

  • eoCRC: EU patients’ perspective and engagement

    Relatore Marianna Vitaloni

    Data Intervento 02/09/2022 - 15:30

  • eoCRC: US patients’ perspective and engagement

    Relatore Anjee Davis

    Data Intervento 02/09/2022 - 15:40

  • Closing remarks

    Relatore -

    Data Intervento 02/09/2022 - 16:20

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Nuovi Progetti: MINUTI DIGITALE



Minuti Menarini Online

Abbonati gratis alla rivista cartacea



Fondazione Internazionale Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Internazionale Menarini.

VGFM DATA-LAYER

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484